These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2627971)

  • 1. Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies.
    Avall Lundqvist E; Nordström L; Sjövall K; Eneroth P
    Eur J Gynaecol Oncol; 1989; 10(6):395-405. PubMed ID: 2627971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
    Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.
    Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C
    Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peri- and postoperative changes in serum levels of four tumor markers and three acute phase reactants in benign and malignant gynecological diseases.
    Avall-Lundqvist E; Sjövall K; Hansson LO; Eneroth P
    Arch Gynecol Obstet; 1992; 251(2):69-78. PubMed ID: 1374604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
    Avall-Lundqvist EH; Sjövall K; Nilsson BR; Eneroth PH
    Eur J Cancer; 1992; 28A(10):1695-702. PubMed ID: 1389488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid.
    Lellé RJ; Henkel E; Leinemann D; Goeschen K
    Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gynecologic malignancies].
    Kato H
    Nihon Rinsho; 1996 Jun; 54(6):1637-41. PubMed ID: 8691622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neopterin. A tumor marker in colorectal carcinoma?
    Putzki H; Aschern F; Henkel E; Heymann H
    Dis Colon Rectum; 1987 Nov; 30(11):879-83. PubMed ID: 3479311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of CA-50 detection in malignant gynecologic tumors].
    Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
    Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A; Facchini V; Bartolini T; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
    Plebani M; Basso D; Navaglia F; De Paoli M; Tommasini A; Cipriani A
    Br J Cancer; 1995 Jul; 72(1):170-3. PubMed ID: 7541234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer.
    Body JJ; Sculier JP; Raymakers N; Paesmans M; Ravez P; Libert P; Richez M; Dabouis G; Lacroix H; Bureau G
    Cancer; 1990 Apr; 65(7):1552-6. PubMed ID: 2311066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-associated antigens CEA, CA125, SCC and TPS in gynaecological cancer.
    Sarandakou A; Phocas I; Botsis D; Sikiotis K; Rizos D; Kalambokis D; Trakakis E; Chryssikopoulos A
    Eur J Gynaecol Oncol; 1998; 19(1):73-7. PubMed ID: 9476065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations of plasma CEA levels in gynecologic malignancies: incidence, significance and changes occurring in response to therapy.
    Lecca U; Marcello C; Medda F; Mattana C; Manca P; Fodde M; Caminiti F
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):150-7. PubMed ID: 7341264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.